3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
Breast
17
CNS
7
Gastrointestinal
6
Lymphoid
5
Genitourinary
5
Other
2
Head & Neck
2
Gynecologic
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Dermatologic
1
Classical hematology
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
397
Leukemia, Myeloid, Acute
385
Leukemia
339
Hematologic Neoplasms
312
Leukemia, Lymphocytic, Chronic, B-Cell
215
Lymphoma
142
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
140
Neoplasms
114
Myelodysplastic Syndromes
108
Multiple Myeloma
98
Lymphoma, Non-Hodgkin
95
Hodgkin Disease
60
Lymphoma, Large B-Cell, Diffuse
56
Lymphoma, Follicular
56
Congenital Abnormalities
52
Lymphoma, Mantle-Cell
49
Burkitt Lymphoma
47
Lymphoma, B-Cell, Marginal Zone
45
Leukemia, Myeloid, Chronic-Phase
45
Myeloproliferative Disorders
42
Leukemia, Myelomonocytic, Chronic
41
Breast Neoplasms
41
Leukemia, Hairy Cell
36
Recurrence
35
Lung Neoplasms
33
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
32
Neoplasms, Plasma Cell
31
Lymphoma, T-Cell, Cutaneous
31
Lymphoma, Large-Cell, Immunoblastic
31
Waldenstrom Macroglobulinemia
28
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Cognitive Dysfunction
×
Other hematologic neoplasm
×
Clear all
NCT02767388
2023-09-29
Chemobrain
University of Nebraska
Completed
45 enrolled
10 charts